Vernakalant
Top View
- An Inventory of Medicinal Products Causing Skin Rash: Clinical and Regulatory Lessons
- BRINAVESS, INN-Vernakalant Hydrochloride
- Esmolol Compared with Amiodarone in the Treatment of Recent-Onset Atrial Fibrillation (Raf): an Emergency Medicine External Validity Study
- Biocatalysis As Useful Tool in Asymmetric Synthesis: an Assessment of Recently Granted Patents (2014–2019)
- Evaluation of the Efficacy and Safety of Different Class III Anti-Arrhythmic
- Hemodynamic Effects of Vernakalant in Cardio-Surgical ICU-Patients Treated for Recent-Onset Postoperative Atrial Fibrillation
- WO 2016/192680 Al 8 December 2016 (08.12.2016) P O P C T
- Vernakalant NDA 22034 Resubmission Preston M
- Vernakalant Dobromir Dobrev, Bashar Hamad and Peter Kirkpatrick
- Vernakalant Hydrochloride in the Treatment of Atrial Fibrillation: a Review of the Latest Clinical Evidence
- Reply to €˜Are Atrial Human Pluripotent Stem Cell-Derived
- Atrial Flutter with 1 : 1 Atrioventricular Conduction After Administration Of
- Generic Pipeline Forecast This Section Provides a Summary of Upcoming First-Time Generic Drugs and Biosimilars That May Be Approved in the Upcoming Two Years